Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2877-2888
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2877
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2877
Table 1 Patient demographics, n = 89
| Variables | Value |
| Gender, n (%) | |
| Male | 51 (57.3) |
| Female | 38 (42.7) |
| Age in yr, mean ± SD | 54.4 ± 10.1 |
| BMI in kg/m2, mean ± SD | 24.9 ± 4.6 |
| ASA score, n (%) | |
| ASA I | 13 (14.6) |
| ASA II | 56 (62.9) |
| ASA III | 20 (22.5) |
| cT stage | |
| cT3 | 54 (60.7) |
| cT4 | 35 (39.3) |
| cN stage | |
| N1 | 50 (56.2) |
| N2 | 39 (43.8) |
| Neoadjuvant chemoradiotherapy | |
| No | 26 (29.2) |
| Short-course radiotherapy | 3 (3.4) |
| Long-course radiotherapy + chemotherapy | 60 (67.4) |
- Citation: Chen JN, Liu Z, Wang ZJ, Mei SW, Shen HY, Li J, Pei W, Wang Z, Wang XS, Yu J, Liu Q. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer. World J Gastroenterol 2020; 26(21): 2877-2888
- URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2877.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i21.2877